Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.5997
-0.0046-0.76%
Post-market: 0.5900-0.0097-1.62%16:59 EDT
Volume:3.70M
Turnover:2.22M
Market Cap:57.77M
PE:-0.94
High:0.6160
Open:0.6100
Low:0.5851
Close:0.6043
52wk High:4.28
52wk Low:0.2522
Shares:96.34M
Float Shares:89.25M
Volume Ratio:0.29
T/O Rate:4.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6355
EPS(LYR):-0.9026
ROE:-916.17%
ROA:-173.70%
PB:-125.83
PE(LYR):-0.66

Loading ...

Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference

GlobeNewswire
·
Oct 29

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Oct 29

Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025

GlobeNewswire
·
Oct 28

Reviva Pharm Holdings Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Oct 27

Reviva Pharmaceuticals Holdings Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Oct 25

Reviva Pharmaceuticals Warned by Nasdaq Over Minimum Bid Price Compliance

Reuters
·
Oct 18

Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

GlobeNewswire
·
Oct 08

Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference

GlobeNewswire
·
Oct 02

Reviva Pharm Holdings Initiated at Buy by Chardan Capital

Dow Jones
·
Sep 29

Chardan Initiates Reviva Pharmaceuticals Holdings at Buy With $2 Price Target

MT Newswires Live
·
Sep 29

Reviva Pharmaceuticals Lowers Stockholder Meeting Quorum to One-Third

Reuters
·
Sep 27

Reviva to Participate in the Lytham Partners Fall 2025 Investor Conference

GlobeNewswire
·
Sep 23

Crude Oil Down 1%; Lennar Earnings Miss Views

Benzinga
·
Sep 20

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 19

Reviva Pharmaceuticals Prices $9 Million Public Offering

MT Newswires Live
·
Sep 19

Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering

THOMSON REUTERS
·
Sep 19

Reviva Pharmaceuticals Plans Public Offering of Shares, Warrants

MT Newswires Live
·
Sep 19

Reviva Pharmaceuticals Shares Down 23% After the Bell; Announces Proposed Public Offering

THOMSON REUTERS
·
Sep 19

Reviva Pharmaceuticals announces common stock, warrants offering

TIPRANKS
·
Sep 19

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

GlobeNewswire
·
Sep 19